Ultra low dose nutraceutical compositions for enhancing sleep quality and treating sleep disorders
US9549982B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2010 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | Jan 27, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2250/712
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present technology relates to a dietary supplement, composition, nutraceutical, and/or system for inducing or treating biological responses or conditions (namely sleep or sleep disorders) which utilize ultra-low dosage amounts of vitamins, minerals, amino acids, co-enzymes, stimulants, and/or similar ingredients in a highly bio-active delivery system which bypasses first pass metabolism. In particular, the present technology relates to a nutraceutical composition/formulation which substantially bypasses first pass metabolism and such as, but not limited to, sleep apnea. Methods of using the composition/formulation to elicit enhanced sleep quality, induce short duration sleep and/or treat sleep disorders are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.